Progesterone Is Being Prescribed to Men. Here's Why That's a Problem.

Some men on hormone therapy aren't getting better. Their energy is flat. Their libido is low. Their labs look reasonable on paper. But they don't feel optimized — and when you look at their protocol, one thing stands out.

Progesterone.

It's in more male protocols than it should be. Some providers include it for "balance." Some offer it as a sleep aid. The intentions may be reasonable. The biology is not.

Progesterone is a powerful hormone. In female physiology, it's essential — stabilizing, protective, deeply beneficial. But the female body evolved to receive it. The male body did not. And the research on what progesterone actually does inside a man makes that distinction impossible to ignore.

Problem 1: Progesterone Drives Inflammation in Men

Start with the data.

A 2005 study published in the Journal of Clinical Endocrinology & Metabolism examined the relationship between progesterone and inflammation in healthy men — not sick men, not men on medications. Healthy men, aged 20 to 50.

In the first arm, researchers measured endogenous progesterone levels and compared them against a panel of inflammation markers. The findings were unambiguous. Higher progesterone tracked directly with elevated IL-6, C-reactive protein, VCAM-1, E-selectin, and neutrophil counts. Every marker moved in the wrong direction as progesterone rose.

The second arm was a controlled trial. Men who received an exogenous progestin alongside testosterone saw IL-6 spike sharply. Anti-inflammatory IL-10 — the body's counter-regulatory response — dropped significantly. Men receiving testosterone alone showed the opposite: their inflammatory profile improved.

The authors concluded directly: progesterone corresponds to an inflammatory profile in healthy men, and exogenous progestins amplify that effect.

This is not a theoretical concern. IL-6 and CRP are not obscure research endpoints. They are markers of systemic inflammation — the same inflammatory burden that drives cardiovascular disease, metabolic dysfunction, insulin resistance, and accelerated biological aging. A protocol increasing that burden isn't optimizing anything. It is working against the very outcomes it claims to support.

Problem 2: Progestins Tell the Male Hormonal Axis to Shut Down

The second problem runs deeper.

Progestins suppress LH and FSH — the gonadotropins that drive endogenous testosterone production. This isn't a side effect. It's a primary pharmacological mechanism. It's exactly why progestins have been studied for decades in male hormonal contraception research: combined with testosterone, they drive pituitary output toward zero and shut down spermatogenesis. This has been demonstrated in clinical trials, published in peer-reviewed literature, and replicated across multiple progestin compounds.

What this means in the context of hormone optimization: adding a progestogen to a male protocol means adding a compound that pharmacologically signals the hypothalamic-pituitary axis to stand down. Less LH. Less FSH. Less endogenous testosterone stimulus.

A man on exogenous testosterone may not feel this acutely — his levels are being replaced. But the axis-level interference doesn't disappear. You are running an optimization protocol with one hand while using the other to suppress the system that protocol depends on.

There is no legitimate optimization rationale for this in men.

Problem 3: This Is the Same Compound Class Used to Eliminate Male Sexual Function

Here is what makes the clinical picture impossible to rationalize.

Progestogens — specifically medroxyprogesterone acetate — are used clinically in the management of male sex offenders. The therapeutic goal is the deliberate suppression of male sexual function. The published literature documents the effects with precision: reduced libido, diminished erectile capacity, decreased sexual arousal, blunted drive.

That is not a side effect. That is the intended mechanism. It is the reason it works for that purpose.

Now consider the population walking into hormone optimization clinics. Men presenting with low libido. Men with erectile dysfunction. Men who feel flat, disengaged, sexually underperforming. These are the exact symptoms that bring people through the door.

And some of those men are being given a compound class whose documented mechanism in male physiology is the suppression of exactly those functions.

That's not an overstatement. It is a direct reading of the published clinical literature. The compound being offered as part of the solution shares a mechanism with drugs used deliberately to eliminate male sexual function.

Why the Confusion Persists

Progesterone has a genuinely impressive clinical profile — in women.

Better sleep. Cardiovascular protection. Mood stability. Endometrial balance. The evidence base in female BHRT is strong. The benefits are real.

The error is transferring that profile across a physiological boundary where it doesn't apply. Steroid hormones don't work the same way in every body. The response depends entirely on the cellular environment receiving the signal: which receptors are expressed, how they're wired, what downstream pathways activate.

Men and women do not run the same hormonal operating system. Progesterone belongs in female physiology. The data on what it does in male physiology — inflammation, gonadotropin suppression, sexual dysfunction — is not ambiguous.

What I See in Practice

When a man comes in not responding to what should be a well-constructed protocol, progesterone is one of the first things I look at.

The presentation is often subtle. Energy that should be better by now. Sleep that hasn't improved the way it should. Libido that isn't where it needs to be. Inflammatory markers on labs that don't have a clean explanation.

Consider a patient in his mid-50s: active, otherwise healthy, two years into testosterone therapy. Testosterone levels optimized. Thyroid addressed. CRP still elevated. Energy inconsistent. His prior protocol included progesterone — added by a previous provider for sleep support.

Removing the progesterone and restructuring the protocol around compounds appropriate for male physiology: CRP normalized. Sleep improved. Energy stabilized. Nothing dramatic was added. Something that didn't belong was removed.

That is frequently how optimization actually works. It isn't always about adding more. It's about identifying what's creating friction and eliminating it.

What Belongs in a Male Hormone Protocol

A well-constructed male protocol is built around what the male endocrine system is designed to use.

Testosterone optimization — not just reaching a reference range, but achieving the balance of free testosterone, total testosterone, estradiol, and SHBG that produces genuine clinical results.

Thyroid — not just TSH, but Free T3, Free T4, and the conversion pathway where the clinically meaningful information actually lives.

DHEA-S and pregnenolone — compounds the male adrenal and neurological systems are equipped to use effectively, frequently low in men presenting with fatigue and cognitive decline.

Progesterone is not on that list. Not because it was overlooked. Because the male endocrine system wasn't built to use it — and three separate lines of clinical evidence explain what happens when it tries.

The same compound class used clinically to suppress male sexual function is appearing in male hormone optimization protocols. That gap between what the data shows and what some providers prescribe is exactly where patient outcomes get lost.

Is Your Protocol Actually Built for You?

If you're on a hormone protocol that includes progesterone and you haven't felt optimized, that's worth examining — not as a coincidence, but as a mechanism.

A thorough evaluation looks at the full panel: free testosterone, SHBG, estradiol, thyroid function, DHEA-S, cortisol, and inflammatory markers. From there, the goal is a protocol built around what your physiology is designed to use.

Virtual consultations are available and the first conversation is free. Bring your labs if you have them. The goal is a straight answer about whether your protocol is actually working for you — or against you.

References

1. Zitzmann M, Erren M, Kamischke A, Simoni M, Nieschlag E. Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men. J Clin Endocrinol Metab. 2005 Dec;90(12):6603–8. — PMID: 16204370

2. Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab. 1996 Nov;81(11):4113–21. — PMID: 8923869

3. Cooper AJ. Progestogens in the treatment of male sex offenders: a review. Can J Psychiatry. 1986 Feb;31(1):73–9. — PMID: 2936441

[DISCLAIMER]

This content is for educational purposes only and does not constitute medical advice. Hormone therapy involves individualized clinical evaluation and is not appropriate for everyone. Always consult a qualified healthcare provider before starting, stopping, or modifying any hormone protocol.